(1)
Guglielmini, P.; Serao, A.; Zai, S.; Piovano, P.; Grosso, F. Second-Line Treatment With Axitinib: An Effective and Well-Tolerated Weapon in the Therapeutic Sequence of Clear Cell Renal Cell Carcinoma. Work Paper Public Hlth 2015, 4.